Corrigendum: Medical management of myxomatous mitral valve disease: An evidence-based veterinary medicine approach

Medical management of myxomatous mitral valve disease: An evidence-based veterinary medicine approach.

Myxomatous mitral valve disease (MMVD) is the most common heart disease of dogs. The current management of MMVD in dogs is mostly pharmacological, and the recommendations for treatment are based on a number of veterinary studies. Notwithstanding the current consensus regarding the medical management of MMVD, there remains active debate as to which drugs are the most effective. In order to under...

Review of Diagnostic and Therapeutic Approach to Canine Myxomatous Mitral Valve Disease

The most common heart disease that affects dogs is myxomatous mitral valve disease. In this article, we review the current diagnostic and therapeutic approaches to this disease, and we also present some of the latest technological advancements in this field.

Corrigendum: Advances in the understanding of the pathogenesis, progression and diagnosis of myxomatous mitral valve disease in dogs

Follow up the Treatment Process of Mitral Valve Diseases by Radiography and Echocardiography in Dogs

Background: Mitral valve disease is the most common acquired heart disease in dogs. Mitral valve regurgitation (MR) due to endocardiosis is an important cause of morbidity and mortality in dog. Echocardiography as a non-invasive tool is routinely used to evaluate and diagnose different disorders in the heart. Objectives: The purpose of this study is to determine the efficacy of medical treatmen...

Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease.

Little is known about the molecular abnormalities associated with canine degenerative mitral valve disease (DMVD). The pathology of DMVD involves the differentiation and activation of the normally quiescent mitral valvular interstitial cell (VIC) into a more active myofibroblast phenotype, which mediates many of the histological and molecular changes in affected the valve tissue. In both humans...